Latest Polyclonal antibodies Stories
PLANTATION, Fla., Jan.
Researchmoz.us announces new research report on Antibody Partnering Terms and Agreements to it's huge collection.
LONDON, Dec. 29, 2014 /PRNewswire/ -- REPORT HIGHLIGHTS The global market for antibody drugs was worth nearly $63.4 billion in 2013.
Symphogen has licensed the rights to the Selexis SUREtechnology Platform™ and SURE CHO-M Cell Line™ for the development of recombinant monoclonal antibody (MAb) mixtures for the treatment
SUZHOU, China, Dec. 8, 2014 /PRNewswire/ -- Adagene Inc.
ROCHESTER, N.Y., Dec. 3, 2014 /PRNewswire/ -- Vaccinex Inc. announced today that Dr.
PhosImmune and PureMHC Working Together On Immunotherapies for Cancer CHARLOTTESVILLE, Va. and AUSTIN, Texas, Oct. 22, 2014 /PRNewswire/ -- PhosImmune Inc.
PLYMOUTH, Minn., Oct.
-- CIAO!(TM) Technology Maximizes Selectivity of Conditionally Active Antibodies -- SAN DIEGO, Oct.
BOCA RATON, Fla., July 2, 2014 /PRNewswire/ -- Biotest Pharmaceuticals Corporation (BPC), a leading developer of immunology biotherapeutic products, is pleased to announce the addition of its
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.